How would you approach a patient with a T3 spindle cell metaplastic breast cancer?
Answer from: Medical Oncologist at NCI-Designated Cancer Center
This is a tough and controversial situation, and hard to reach a consensus due to the paucity of prospective data specifically focused on this subtype. The data available suggest that these tumors are less responsive to chemotherapy. Given these concerns for chemorefractoriness, I generally favor pa...